Cargando…
The Impact of Colchicine on COVID-19 patients: A Clinical Trial Study
BACKGROUND: Severe acute respiratory syndrome due to COVID-19 infection has evolved into a global pandemic. This study has been designed to evaluate colchicine as an anti-inflammatory agent among COVID-19 patients regarding the disease course, duration of hospitalisation, and its morbidity and morta...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Mediterranean Journal of Rheumatology (MJR)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450200/ https://www.ncbi.nlm.nih.gov/pubmed/36128202 http://dx.doi.org/10.31138/mjr.33.2.232 |